Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3097 Target Snapshot

Acetylcholine receptor subunit alpha · SINGLE PROTEIN · Torpedo californica

31Compounds
26Assays
6Approved Drugs
54.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P02710. Use UniProt P02710 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P02710 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acetylcholine receptor subunit alpha as ChEMBL target CHEMBL3097, mapped to UniProt P02710. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acetylcholine receptor subunit alpha
SINGLE PROTEIN · Torpedo californica
As of 2026-09-13
ChEMBL target ID
CHEMBL3097
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P02710
Acetylcholine receptor subunit alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acetylcholine receptor subunit alpha is the right protein anchor across sources, using UniProt P02710 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAcetylcholine receptor subunit alpha
UniProt AccessionP02710
Component TypeProtein
Sequence Length461 aa

Acetylcholine receptor subunit alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acetylcholine receptor subunit alpha, mapped to UniProt P02710. Sequence length is 461 aa.

Mapped IDP02710
Review nameAcetylcholine receptor subunit alpha
OrganismTorpedo californica
Clinical Profile

Clinical Phase Distribution

6
Approved
1
Phase III
4
Phase II
Assay Mix

Activity Type Distribution

IC5050.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL275528 6.66 IC50 217.0 Clinical
CHEMBL279676 6.62 IC50 237.0 Clinical
CHEMBL59986 6.5 Ki 314.0 Preclinical
CHEMBL262769 6.42 Ki 384.0 Preclinical
CHEMBL267936 6.22 IC50 596.0 Approved
CHEMBL122270 6.0 IC50 1010.0 Clinical
CHEMBL71 5.89 IC50 1280.0 Approved
CHEMBL430497 5.47 Ki 3400.0 Clinical
CHEMBL497939 5.45 IC50 3530.0 Clinical
CHEMBL742 5.3 IC50 4950.0 Approved
Distribution

pChEMBL Value Distribution

8
5.0
3
5.5
3
6.0
3
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MECAMYLAMINE
CHEMBL267936
Approved 1956
Assay Landscape

Assay Landscape

26
Total Assays
29
Tested Compounds
2
Assay Types
Binding — 25 assays, 29 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 17 20 5.3
single protein format 8 9 5.5
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine